Agilon Health (NYSE:AGL) Sets New 1-Year High – Here’s Why

Agilon Health, Inc. (NYSE:AGL)’s share price reached a new 52-week high on Wednesday . The company traded as high as $126.00 and last traded at $124.9840, with a volume of 210302 shares traded. The stock had previously closed at $122.61.

Wall Street Analyst Weigh In

AGL has been the topic of several analyst reports. Weiss Ratings lowered Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 27th. Benchmark restated a “buy” rating and issued a $95.00 price target (up from $13.00) on shares of Agilon Health in a research report on Thursday, May 21st. Barclays raised shares of Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price objective for the company in a report on Tuesday, May 26th. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Finally, Jefferies Financial Group upgraded Agilon Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $27.50 to $48.00 in a research report on Thursday, May 7th. Five research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat, Agilon Health presently has an average rating of “Hold” and an average target price of $64.00.

Agilon Health Price Performance

The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04. The company has a 50-day moving average price of $99.33 and a 200-day moving average price of $46.95. The firm has a market capitalization of $2.01 billion, a P/E ratio of -5.59 and a beta of 2.98.

Agilon Health (NYSE:AGL) last released its earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.76. The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. On average, sell-side analysts predict that Agilon Health, Inc. will post -3.5 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the stock. LPL Financial LLC lifted its stake in Agilon Health by 213.4% in the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock valued at $30,000 after acquiring an additional 30,000 shares in the last quarter. Krilogy Financial LLC bought a new position in Agilon Health during the fourth quarter worth about $34,000. CIBC Bancorp USA Inc. acquired a new position in Agilon Health during the third quarter worth approximately $34,000. Merit Financial Group LLC bought a new stake in Agilon Health in the fourth quarter valued at approximately $35,000. Finally, Focus Partners Advisor Solutions LLC bought a new stake in Agilon Health in the fourth quarter valued at approximately $53,000.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.